Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03060024 5-HETE cPLA2i 1.0 BCD110605C28 1.14 pmol/ml medium
LMFA03060024 5-HETE cPLA2i 1.0 BCD110605C30 1.24 pmol/ml medium
LMFA03060024 5-HETE cPLA2i 1.0 BCD110605C29 1.25 pmol/ml medium
LMFA03060024 5-HETE cPLA2i 20.0 BCD110605C64 1.9 pmol/ml medium
LMFA03060024 5-HETE cPLA2i 20.0 BCD110605C66 2.01 pmol/ml medium
LMFA03060024 5-HETE cPLA2i 20.0 BCD110605C65 1.96 pmol/ml medium
LMFA03060024 5-HETE PLDi 1.0 BCD110605C16 1.2 pmol/ml medium
LMFA03060024 5-HETE PLDi 1.0 BCD110605C17 1.17 pmol/ml medium
LMFA03060024 5-HETE PLDi 1.0 BCD110605C18 1.13 pmol/ml medium
LMFA03060024 5-HETE PLDi 20.0 BCD110605C54 2.55 pmol/ml medium
LMFA03060024 5-HETE PLDi 20.0 BCD110605C52 2.7 pmol/ml medium
LMFA03060024 5-HETE PLDi 20.0 BCD110605C53 2.83 pmol/ml medium
LMFA03060024 5-HETE KDO+cPLA2i 1.0 BCD110605C32 0.946 pmol/ml medium
LMFA03060024 5-HETE KDO+cPLA2i 1.0 BCD110605C31 0.935 pmol/ml medium
LMFA03060024 5-HETE KDO+cPLA2i 1.0 BCD110605C33 0.941 pmol/ml medium
LMFA03060024 5-HETE KDO+cPLA2i 20.0 BCD110605C68 1.14 pmol/ml medium
LMFA03060024 5-HETE KDO+cPLA2i 20.0 BCD110605C69 1.01 pmol/ml medium
LMFA03060024 5-HETE KDO+cPLA2i 20.0 BCD110605C67 1.11 pmol/ml medium
LMFA03060024 5-HETE KDO+PLDi 1.0 BCD110605C19 0.882 pmol/ml medium
LMFA03060024 5-HETE KDO+PLDi 1.0 BCD110605C20 0.943 pmol/ml medium
LMFA03060024 5-HETE KDO+PLDi 1.0 BCD110605C21 0.962 pmol/ml medium
LMFA03060024 5-HETE KDO+PLDi 20.0 BCD110605C56 1.2 pmol/ml medium
LMFA03060024 5-HETE KDO+PLDi 20.0 BCD110605C57 1.27 pmol/ml medium
LMFA03060024 5-HETE KDO+PLDi 20.0 BCD110605C55 1.49 pmol/ml medium
LMFA03060024 5-HETE KDO+ATP+cPLA2i 1.0 BCD110605C37 0.881 pmol/ml medium
LMFA03060024 5-HETE KDO+ATP+cPLA2i 1.0 BCD110605C38 0.762 pmol/ml medium
LMFA03060024 5-HETE KDO+ATP+cPLA2i 1.0 BCD110605C39 0.889 pmol/ml medium
LMFA03060024 5-HETE KDO+ATP+cPLA2i 20.0 BCD110605C74 0.618 pmol/ml medium
LMFA03060024 5-HETE KDO+ATP+cPLA2i 20.0 BCD110605C75 0.528 pmol/ml medium
LMFA03060024 5-HETE KDO+ATP+cPLA2i 20.0 BCD110605C73 0.613 pmol/ml medium
LMFA03060024 5-HETE KDO+ATP+PLDi 1.0 BCD110605C25 0.978 pmol/ml medium
LMFA03060024 5-HETE KDO+ATP+PLDi 1.0 BCD110605C27 0.838 pmol/ml medium
LMFA03060024 5-HETE KDO+ATP+PLDi 1.0 BCD110605C26 0.881 pmol/ml medium
LMFA03060024 5-HETE KDO+ATP+PLDi 20.0 BCD110605C61 0.633 pmol/ml medium
LMFA03060024 5-HETE KDO+ATP+PLDi 20.0 BCD110605C62 0.686 pmol/ml medium
LMFA03060024 5-HETE KDO+ATP+PLDi 20.0 BCD110605C63 0.496 pmol/ml medium
LMFA03060024 5-HETE KDO + ATP 1.0 BCD110605C15 0.913 pmol/ml medium
LMFA03060024 5-HETE KDO + ATP 1.0 BCD110605C14 0.879 pmol/ml medium
LMFA03060024 5-HETE KDO + ATP 1.0 BCD110605C13 1.21 pmol/ml medium
LMFA03060024 5-HETE KDO + ATP 20.0 BCD110605C49 0.803 pmol/ml medium
LMFA03060024 5-HETE KDO + ATP 20.0 BCD110605C50 0.687 pmol/ml medium
LMFA03060024 5-HETE KDO + ATP 20.0 BCD110605C51 0.654 pmol/ml medium
LMFA03060024 5-HETE KDO 1.0 BCD110605C08 0.869 pmol/ml medium
LMFA03060024 5-HETE KDO 1.0 BCD110605C07 0.933 pmol/ml medium
LMFA03060024 5-HETE KDO 1.0 BCD110605C09 0.847 pmol/ml medium
LMFA03060024 5-HETE KDO 20.0 BCD110605C45 1.39 pmol/ml medium
LMFA03060024 5-HETE KDO 20.0 BCD110605C44 1.53 pmol/ml medium
LMFA03060024 5-HETE KDO 20.0 BCD110605C43 1.37 pmol/ml medium
LMFA03060024 5-HETE C 0.0 BCD110605C03 0.83 pmol/ml medium
LMFA03060024 5-HETE C 0.0 BCD110605C01 1.08 pmol/ml medium